Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403)

A multicentre phase II trial of stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer was initiated in Japan as the Japan Clinical Oncology Group trial (JCOG0403). Before starting the trial, a decision was made to evaluate the treatment machine and treatment planning in participating institutions to minimize the variations of the prescription dose between the institutions. We visited the 16 participating institutions and examined the absolute dose at the centre of a simulated spherical tumour of 3.0 cm diameter in the lung using the radiation treatment planning systems in each institution. A lung phantom for stereotactic body radiotherapy (SBRT) was developed and used for the treatment planning and film dosimetry. In the JCOG radiotherapy study group, the no model-based calculation algorithm or the model-based calculation algorithm with a dose kernel unscaled for heterogeneities were selected for use in the initial SBRT trials started in 2004, and the model-based calculation algorithm with a dose kernel scaled for heterogeneities was selected for the coming trial. The findings of this study suggest that the clinical results of lung SBRT trials should be carefully evaluated in comparison with the actual dose given to patients.

[1]  Lech Papiez,et al.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. , 2005, International journal of radiation oncology, biology, physics.

[2]  M. Kissick,et al.  Low dose fraction behavior of high sensitivity radiochromic film. , 2005, Medical physics.

[3]  C. McCollough,et al.  The calibration of experimental self-developing Gafchromic HXR film for the measurement of radiation dose in computed tomography. , 2005, Medical physics.

[4]  Lei Dong,et al.  Retrospective analysis of 2D patient-specific IMRT verifications. , 2005, Medical physics.

[5]  J. Fowler,et al.  Erratum: A challenge to traditional radiation oncology (International Journal of Radiation Oncology Biology (2004) 60 (1241-1256)) , 2005 .

[6]  Lei Dong,et al.  Dosimetric accuracy of Kodak EDR2 film for IMRT verifications. , 2005, Medical physics.

[7]  I. Rosen,et al.  Detection of IMRT delivery errors using a quantitative 2D dosimetric verification system. , 2004, Medical physics.

[8]  John D Fenwick,et al.  A challenge to traditional radiation oncology. , 2004, International journal of radiation oncology, biology, physics.

[9]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[10]  I. Rosen,et al.  Effect of processing time delay on the dose response of Kodak EDR2 film. , 2004, Medical physics.

[11]  Hiroshi Onishi,et al.  Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. , 2004, Lung cancer.

[12]  M. Bucciolini,et al.  Verification of IMRT fields by film dosimetry. , 2003, Medical physics.

[13]  A. Boyer,et al.  Tissue Inhomogeneity Corrections for Megavoltage Photon Beams , 2004 .

[14]  Stephanie Frost,et al.  Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. , 2003, Chest.

[15]  Shinichi Shimizu,et al.  Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. , 2003, International journal of radiation oncology, biology, physics.

[16]  M. Nishimura,et al.  Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas , 2002, Cancer.

[17]  Lei Dong,et al.  Rapid radiographic film calibration for IMRT verification using automated MLC fields. , 2002, Medical physics.

[18]  Y. Shibamoto,et al.  Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. , 2001, International journal of radiation oncology, biology, physics.

[19]  J. Wong,et al.  Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.

[20]  K Nakagawa,et al.  Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. , 2000, International journal of radiation oncology, biology, physics.

[21]  M. Uematsu,et al.  A dual computed tomography linear accelerator unit for stereotactic radiation therapy: a new approach without cranially fixated stereotactic frames. , 1996, International journal of radiation oncology, biology, physics.

[22]  I. Lax,et al.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.

[23]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .